• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (oesophageal or gastro-oesophageal junction cancer) - Benefit assessment according to §35a Social Code Book V]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dapagliflozin (kidney disease) - Benefit assessment according to §35a Social Code Book V]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guideline synopsis for updating the DMP "Heart failure"]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Angiotensin II acetate (refractory hypotension in distributive shock) - Addendum to Commission A21-95]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vericiguat (cardiac failure) - Benefit assessment according to §35a Social Code Book V]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Roxadustat (anaemia) - Benefit assessment according to §35a Social Code Book V]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tafasitamab (diffuse large cell B-cell lymphoma, combination with lenalidomide) - Assessment according to § 35a (1), Sentence 11, Social Code Book V]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Odevixibat (cholestasis [from 6 months]) - Assessment according to § 35a (1), Sentence 11, Social Code Book V]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cemiplimab (basal cell carcinoma) - Addendum to Commission A21-97]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ravulizumab (paroxysmal nocturnal haemoglobinuria) - Benefit assessment according to §35a Social Code Book V]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Review of the study protocol and statistical analysis plan on routine practice data collection for onasemnogene abeparvovec - Second addendum to Commission A20-61]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lumacaftor/ivacaftor (cystic fibrosis, homozygous F508del mutation in the CFTR gene, 2-5 years) - Benefit assessment according to §35a Social Code Book V (expiry of the limitation period)]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence on orphan drugs]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Mepolizumab (hypereosinophilic syndrome) - Benefit assessment according to §35a Social Code Book V]
2021 Canadian Agency for Drugs and Technologies in Health (CADTH) Remote monitoring programs for cardiac conditions
2021 Malaysian Health Technology Assessment (MaHTAS) Proton beam therapy for the treatment of cancer - an update
2021 Malaysian Health Technology Assessment (MaHTAS) Rezūm therapy for management of benign prostatic hyperplasia
2021 Malaysian Health Technology Assessment (MaHTAS) 5-aminolevulinic acid (5-ALA) for brain tumour surgical procedure
2021 Malaysian Health Technology Assessment (MaHTAS) Single dose rifampicin (SDR) as a prophylaxis for leprosy contacts
2021 Malaysian Health Technology Assessment (MaHTAS) Versajet hydrosurgery system for wound debridement: an update
2021 Belgian Health Care Knowledge Centre (KCE) Do innovative medicines against cancer always have a real added value?
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Glecaprevir/pibrentasvir (chronic hepatitis C in children) - Benefit assessment according to §35a Social Code Book V]
2021 Institute for Clinical Effectiveness and Health Policy (IECS) [Edaravone in patients with amyotrophic lateral sclerosis]
2021 Institute for Clinical Effectiveness and Health Policy (IECS) [Botulinum toxin in adult patients with overactive bladder]
2021 Institute for Clinical Effectiveness and Health Policy (IECS) [Vosoritide in achondroplasia]
2021 Institute for Clinical Effectiveness and Health Policy (IECS) [Auditory integration therapy for autism spectrum disorders]
2021 Institute for Clinical Effectiveness and Health Policy (IECS) [Intense-pulse-light therapy treatment for dry eye syndrome]
2021 Institute for Clinical Effectiveness and Health Policy (IECS) [Tafamidis for transthyretin amyloid cardiomyopathy]
2021 Adelaide Health Technology Assessment (AHTA) Small gene panel testing for non-small cell lung carcinoma
2021 Adelaide Health Technology Assessment (AHTA) Whole genome sequencing of antimicrobial-resistant pathogens
2021 Adelaide Health Technology Assessment (AHTA) Genetic testing for childhood hearing impairment
2021 NIHR Health Technology Assessment programme Feasibility of a RCT of techniques for managing an impacted fetal head during emergency caesarean section: the MIDAS scoping study
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Acalabrutinib (pretreated chronic lymphocytic leukaemia) - Second Addendum to Commission A20-105]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cemiplimab (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (colorectal cancer) - Benefit assessment according to §35a Social Code Book V]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Internet- or mobile-based cognitive behavioral therapy for insomnia - Evidence report for the S3 guideline on non-restorative sleep/sleep disorders - Insomnia in adults]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vandetanib (medullary thyroid cancer) - Benefit assessment according to §35a Social Code Book V (expiry of the limitation period)]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vosoritide (achondroplasia) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2021 Canary Health Service [Effectiveness and safety of foot reflexology]
2021 Canary Health Service [Efficacy and safety of floral therapy]
2021 Canary Health Service [Telemedicine for the management of consultations, evaluations and therapeutic management in neurological diseases]
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ventral rectopexy for the treatment of rectal prolapse and intussusception
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Endoscopic sleeve gastroplasty for the treatment of patients with Class I and II obesity who have failed first-line (lifestyle modification) and second-line (VLED/pharmacotherapy) treatments
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Permanent acute coronary syndrome event detector (insertion, removal or replacement of) for monitoring of the heart's electrical activity
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Modification of the wording of minimally invasive glaucoma surgery (MIGS) existing item number to encompass the use of a microcatheter
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Modification of the wording of minimally invasive glaucoma surgery (MIGS) existing item number to encompass the use of a microcatheter
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Alpha-1 antitrypsin genotyping
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Streamlining Medicare Benefits Schedule items for positron emission tomography (PET) project
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Artificial intelligence in surgery and surgical education
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Effectiveness and safety of vitamin B12 tests
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Long-term physiotherapy in patients after stroke, with multiple sclerosis, or with Parkinson's disease
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ezetimibe-containing medicines for the treatment of hypercholesterolaemia and mixed/combined hyperlipidaemia
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Denosumab (Prolia) for the treatment of osteoporosis
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Subacromial decompression as a primary/isolated intervention to treat subacromial pain
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Corneal collagen crosslinking for the treatment of progressive keratoconus
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Triphasic biomaterial for augmentation of the osteoporotic femoral neck
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Global HTA: past, present, and future
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) In hospital survival after pancreatoduodenectomy is greater in high volume hospitals versus lower volume hospitals: a meta analysis
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) COVID-19: a test of evidence-based surgery
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Evidence, not eminence, for surgical management during COVID-19: a multifaceted systematic review and a model for rapid clinical change
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Influence of COVID-19 vaccines on surgical practice
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Proposed delay for safe surgery after COVID-19
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Telehealth in surgery: an umbrella review
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Delaying surgery for patients recovering from COVID-19. A rapid review comissioned by RACS
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) National spending and uptake of mobile radiology services in aged care facilities: an opportunity to improve access remains
2021 Canary Health Service [Real-time continuous glucose monitoring device for gestational diabetes]
2021 Canary Health Service [Monitoring study: "The sensor glucose monitoring system (flash-type) for type 1 diabetes mellitus in childhood and adolescence"]
2021 Canary Health Service [Effectiveness, safety, and cost-effectiveness of devices for peripheral venous catheterization: needleless connectors, passive disinfection caps and prefilled saline syringes]
2021 Canary Health Service [Decisional flowchart for patient involvement in health technology assessments]
2021 Canary Health Service [Scalp cooling devices for the prevention of chemotherapy-induced alopecia]
2021 Canary Health Service [Prenatal screening for toxoplasmosis]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cold plasma in wound therapy (Addendum to Commission E21-03)]
2021 Health Sciences Institute in Aragon (IACS) [Clinical effectiveness of sFlt-1 to PlGF ratio tests for the evaluation of preeclampsia]
2021 Agency for Healthcare Research and Quality (AHRQ) Automated-entry patient-generated health data for chronic conditions: the evidence on health outcomes
2021 Agency for Healthcare Research and Quality (AHRQ) Breast reconstruction after mastectomy
2021 Agency for Healthcare Research and Quality (AHRQ) Care coordination and care plans for transitions across care settings
2021 Agency for Healthcare Research and Quality (AHRQ) Cervical ripening in the outpatient setting
2021 Agency for Healthcare Research and Quality (AHRQ) Disparities and barriers to pediatric cancer survivorship care
2021 Agency for Healthcare Research and Quality (AHRQ) Integrated and comprehensive pain management programs: effectiveness and harms
2021 Agency for Healthcare Research and Quality (AHRQ) Integrating palliative care in ambulatory care of noncancer serious chronic illness: a mixed-methods review
2021 Agency for Healthcare Research and Quality (AHRQ) Interventional treatments for acute and chronic pain: systematic review
2021 Agency for Healthcare Research and Quality (AHRQ) Interventions to decrease hospital length of stay
2021 Agency for Healthcare Research and Quality (AHRQ) Malnutrition in hospitalized adults
2021 Agency for Healthcare Research and Quality (AHRQ) Management of high-need, high-cost patients: a "best fit" framework synthesis, realist review, and systematic review
2021 Agency for Healthcare Research and Quality (AHRQ) Maternal, fetal, and child outcomes of mental health treatments in women: a systematic review of perinatal pharmacologic interventions
2021 Agency for Healthcare Research and Quality (AHRQ) Physical activity and the health of wheelchair users: a systematic review in multiple sclerosis, cerebral palsy, and spinal cord injury
2021 Agency for Healthcare Research and Quality (AHRQ) Prehabilitation and rehabilitation for major joint replacement
2021 Agency for Healthcare Research and Quality (AHRQ) Prehospital airway management
2021 Agency for Healthcare Research and Quality (AHRQ) Radiation therapy for brain metastases
2021 Agency for Healthcare Research and Quality (AHRQ) Safety of vaccines used for routine immunization in the United States: an update
2021 Agency for Healthcare Research and Quality (AHRQ) Treatments and technologies supporting appropriate opioid tapers
2021 Agency for Healthcare Research and Quality (AHRQ) Treatments, technologies, and models for management of acute and chronic pain in people with a history of substance use disorder
2021 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Antithrombotic treatments following heart valve replacement surgeries]
2021 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Respiratory rehabilitation following hospitalization related to a diagnosis of COVID-19]
2021 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Validity of thermometers for peripheral temperature measurement]
2021 Canadian Agency for Drugs and Technologies in Health (CADTH) Phosphodiesterase type-5 inhibitors for the treatment of secondary Raynaud's phenomenon and digital ulcers
2021 Canadian Agency for Drugs and Technologies in Health (CADTH) Autologous hematopoietic cell transplant for patients with multiple sclerosis
2021 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Sentinel lymph node biopsy in oral cavity carcinoma: clinical effectiveness, safety, and cost-effectiveness]
2021 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Systematic review about effectiveness of digital pathology as a diagnostic tool for pathology and cytopathology]
2021 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Efficacy and safety of yoga on selected clinical conditions]